Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes 465,533 options ("Options") exercisable into 465,533 Ordinary shares and (viii) 92,821 warrants ("Warrants") exercisable into 92,821 Ordinary shares that are currently exercisable or will be exercisable within 60 days after December 31, 2025. (2) This amount of shares and percentage relates to all the Reporting Persons and is based on 5,179,378 Ordinary Shares of the Issuer's issued and outstanding as of February 20, 2026, which number was provided to the Reporting Person by the Issuer, plus the 465,533 Ordinary Shares of the Issuer issuable upon the exercise of the Options and the 92,821 Ordinary Shares of the Issuer issuable upon the exercise of the Warrants.


SCHEDULE 13G



 
Dr. Ehud Geller
 
Signature:/s/ Ehud Geller
Name/Title:Ehud Geller
Date:02/17/2026
 
Medica III Investments (International) L.P.
 
Signature:/s/ Ehud Geller
Name/Title:Ehud Geller/General Partner
Date:02/17/2026
 
Medica III Investments (Israel) L.P.
 
Signature:/s/ Ehud Geller
Name/Title:Ehud Geller/General Partner
Date:02/17/2026
 
Medica III Investments (S.F.) L.P.
 
Signature:/s/ Ehud Geller
Name/Title:Ehud Geller/General Partner
Date:02/17/2026
 
Medica III Investments (P.F.) L.P.
 
Signature:/s/ Ehud Geller
Name/Title:Ehud Geller/General Partner
Date:02/17/2026
 
Medica III Investments Israel (B) L.P.
 
Signature:/s/ Ehud Geller
Name/Title:Ehud Geller/General Partner
Date:02/17/2026
 
Poalim Medica III Investments L.P.
 
Signature:/s/ Ehud Geller
Name/Title:Ehud Geller/General Partner
Date:02/17/2026